NextCure (NXTC) Cash from Operations (2018 - 2026)
NextCure (NXTC) posted quarterly Cash from Operations of 13363000.0 for Q1 2026, down 2.84% year-over-year from 13753570.06 in Q1 2025, and down 74.95% quarter-over-quarter from 7638000.0 in Q4 2025.
NextCure (NXTC) Cash from Operations (2018 - 2026) Analysis & Trends
NextCure's Cash from Operations history runs 9 years deep, the most recent figure standing at 13363000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 2.84% year-over-year to 13363000.0; the TTM figure through Mar 2026 stood at 49982000.0 (down 21.34% YoY), while the FY2025 annual figure was 49613000.0, down 21.59% from the prior year.
- Cash from Operations for Q1 2026 stood at 13363000.0, down from 7638000.0 in the prior quarter.
- The five-year high for Cash from Operations was 6268000.0 in Q3 2025, with the low at 22713000.0 in Q2 2025.
- The 5-year median for Cash from Operations is 12778000.0 (2023), against an average of 12390647.06.
- Peak annual rise in Cash from Operations reached 45.28% in 2025, while the deepest fall reached 132.33% in 2025.
- NextCure's Cash from Operations stood at 8949000.0 in 2022, then dropped by 19.23% to 10670000.0 in 2023, then surged by 34.69% to 6969000.0 in 2024, then slipped by 9.6% to 7638000.0 in 2025, then plunged by 74.95% to 13363000.0 in 2026.
- Business Quant data shows NXTC's Cash from Operations at 13363000.0 in Q1 2026, 7638000.0 in Q4 2025, and 6268000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | NextCure | 33.72 Mn | 33.72 Mn | - | -9.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.72 Mn |
| Jun 30, 2026 | -9.72 Mn |
| Mar 31, 2026 | -13.36 Mn |
| Mar 31, 2026 | -13.36 Mn |
| Dec 31, 2025 | -7.64 Mn |
| Dec 31, 2025 | -7.64 Mn |
| Sep 30, 2025 | -6.27 Mn |
| Sep 30, 2025 | -6.27 Mn |
| Jun 30, 2025 | -22.71 Mn |
| Jun 30, 2025 | -22.71 Mn |
| Mar 31, 2025 | -12.99 Mn |
| Mar 31, 2025 | -12.99 Mn |
| Dec 31, 2024 | -6.97 Mn |
| Dec 31, 2024 | -6.97 Mn |
| Sep 30, 2024 | -11.45 Mn |
| Sep 30, 2024 | -11.45 Mn |
| Jun 30, 2024 | -9.78 Mn |
| Jun 30, 2024 | -9.78 Mn |
| Mar 31, 2024 | -12.61 Mn |
| Mar 31, 2024 | -12.61 Mn |